Elevation of high density lipoprotein cholesterol and not anti-inflammatory effect accounts for the reduction in clinical events with combination gemfibrozil, niacin and cholestyramine therapy

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Krasuski, R; Whitney, E; Kolasa, M; Zagol, B; Personius, B; Michalek, J; Brown, B; Gotto, A

Published Date

  • 2004

Published In

Volume / Issue

  • 25 /

Start / End Page

  • 50 - 50

Electronic International Standard Serial Number (EISSN)

  • 1522-9645

International Standard Serial Number (ISSN)

  • 0195-668X